Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 127

Cited In for PubMed (Select 9490415)

1.

NKG2D Receptor and Its Ligands in Host Defense.

Lanier LL.

Cancer Immunol Res. 2015 Jun;3(6):575-82. doi: 10.1158/2326-6066.CIR-15-0098. Review.

PMID:
26041808
2.

Transmembrane Complexes of DAP12 Crystallized in Lipid Membranes Provide Insights into Control of Oligomerization in Immunoreceptor Assembly.

Knoblich K, Park S, Lutfi M, van 't Hag L, Conn CE, Seabrook SA, Newman J, Czabotar PE, Im W, Call ME, Call MJ.

Cell Rep. 2015 May 26;11(8):1184-92. doi: 10.1016/j.celrep.2015.04.045. Epub 2015 May 14.

3.

DAP12 Stabilizes the C-terminal Fragment of the Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) and Protects against LPS-induced Pro-inflammatory Response.

Zhong L, Chen XF, Zhang ZL, Wang Z, Shi XZ, Xu K, Zhang YW, Xu H, Bu G.

J Biol Chem. 2015 Jun 19;290(25):15866-77. doi: 10.1074/jbc.M115.645986. Epub 2015 May 8.

PMID:
25957402
4.

Generation of Potent T-cell Immunotherapy for Cancer Using DAP12-Based, Multichain, Chimeric Immunoreceptors.

Wang E, Wang LC, Tsai CY, Bhoj V, Gershenson Z, Moon E, Newick K, Sun J, Lo A, Baradet T, Feldman MD, Barrett D, Puré E, Albelda S, Milone MC.

Cancer Immunol Res. 2015 Jul;3(7):815-26. doi: 10.1158/2326-6066.CIR-15-0054. Epub 2015 May 4.

PMID:
25941351
5.

NKG2D Ligands in Tumor Immunity: Two Sides of a Coin.

Zhang J, Basher F, Wu JD.

Front Immunol. 2015 Mar 4;6:97. doi: 10.3389/fimmu.2015.00097. eCollection 2015. Review.

6.

Induction of indoleamine 2, 3-dioxygenase in human dendritic cells by a cholera toxin B subunit-proinsulin vaccine.

Mbongue JC, Nicholas DA, Zhang K, Kim NS, Hamilton BN, Larios M, Zhang G, Umezawa K, Firek AF, Langridge WH.

PLoS One. 2015 Feb 25;10(2):e0118562. doi: 10.1371/journal.pone.0118562. eCollection 2015.

7.

The C-type lectin OCILRP2 costimulates EL4 T cell activation via the DAP12-Raf-MAP kinase pathway.

Lou Q, Zhang W, Liu G, Ma Y.

PLoS One. 2014 Nov 20;9(11):e113218. doi: 10.1371/journal.pone.0113218. eCollection 2014.

8.

Molecular dynamic simulation of the self-assembly of DAP12-NKG2C activating immunoreceptor complex.

Wei P, Xu L, Li CD, Sun FD, Chen L, Tan T, Luo SZ.

PLoS One. 2014 Aug 22;9(8):e105560. doi: 10.1371/journal.pone.0105560. eCollection 2014.

9.

Human NKG2E is expressed and forms an intracytoplasmic complex with CD94 and DAP12.

Orbelyan GA, Tang F, Sally B, Solus J, Meresse B, Ciszewski C, Grenier JC, Barreiro LB, Lanier LL, Jabri B.

J Immunol. 2014 Jul 15;193(2):610-6. doi: 10.4049/jimmunol.1400556. Epub 2014 Jun 16.

10.

DAP12 deficiency in liver allografts results in enhanced donor DC migration, augmented effector T cell responses and abrogation of transplant tolerance.

Yoshida O, Kimura S, Dou L, Matta BM, Yokota S, Ross MA, Geller DA, Thomson AW.

Am J Transplant. 2014 Aug;14(8):1791-805. doi: 10.1111/ajt.12757. Epub 2014 Jun 16.

11.

Activating killer cell Ig-like receptors in health and disease.

Ivarsson MA, Michaëlsson J, Fauriat C.

Front Immunol. 2014 Apr 22;5:184. doi: 10.3389/fimmu.2014.00184. eCollection 2014. Review.

12.

Brain innate immunity in the regulation of neuroinflammation: therapeutic strategies by modulating CD200-CD200R interaction involve the cannabinoid system.

Hernangómez M, Carrillo-Salinas FJ, Mecha M, Correa F, Mestre L, Loría F, Feliú A, Docagne F, Guaza C.

Curr Pharm Des. 2014;20(29):4707-22. Review.

13.

The biology of NK cells and their receptors affects clinical outcomes after hematopoietic cell transplantation (HCT).

Foley B, Felices M, Cichocki F, Cooley S, Verneris MR, Miller JS.

Immunol Rev. 2014 Mar;258(1):45-63. doi: 10.1111/imr.12157. Review.

14.

Contribution of the Ly49E natural killer receptor in the immune response to Plasmodium berghei infection and control of hepatic parasite development.

Filtjens J, Foquet L, Taveirne S, Van Ammel E, Vanhees M, Van Acker A, Kerre T, Taghon T, Vandekerckhove B, Plum J, Van den Steen PE, Leclercq G.

PLoS One. 2014 Jan 30;9(1):e87463. doi: 10.1371/journal.pone.0087463. eCollection 2014.

15.

A potential role of myeloid DAP12-associating lectin (MDL)-1 in the regulation of inflammation in rheumatoid arthritis patients.

Chen DY, Yao L, Chen YM, Lin CC, Huang KC, Chen ST, Lan JL, Hsieh SL.

PLoS One. 2014 Jan 21;9(1):e86105. doi: 10.1371/journal.pone.0086105. eCollection 2014.

16.

Induction of myelodysplasia by myeloid-derived suppressor cells.

Chen X, Eksioglu EA, Zhou J, Zhang L, Djeu J, Fortenbery N, Epling-Burnette P, Van Bijnen S, Dolstra H, Cannon J, Youn JI, Donatelli SS, Qin D, De Witte T, Tao J, Wang H, Cheng P, Gabrilovich DI, List A, Wei S.

J Clin Invest. 2013 Nov;123(11):4595-611.

17.

Sequential proteolytic processing of the triggering receptor expressed on myeloid cells-2 (TREM2) protein by ectodomain shedding and γ-secretase-dependent intramembranous cleavage.

Wunderlich P, Glebov K, Kemmerling N, Tien NT, Neumann H, Walter J.

J Biol Chem. 2013 Nov 15;288(46):33027-36. doi: 10.1074/jbc.M113.517540. Epub 2013 Sep 27.

18.

Analysis of the host transcriptome from demyelinating spinal cord of murine coronavirus-infected mice.

Elliott R, Li F, Dragomir I, Chua MM, Gregory BD, Weiss SR.

PLoS One. 2013 Sep 18;8(9):e75346. doi: 10.1371/journal.pone.0075346. eCollection 2013.

19.

A physical interaction between the adaptor proteins DOK3 and DAP12 is required to inhibit lipopolysaccharide signaling in macrophages.

Peng Q, Long CL, Malhotra S, Humphrey MB.

Sci Signal. 2013 Aug 20;6(289):ra72. doi: 10.1126/scisignal.2003801.

20.

Environmental factors determine DAP12 deficiency to either enhance or suppress immunopathogenic processes.

Montalvo V, Quigley L, Vistica BP, Boelte KC, Nugent LF, Takai T, McVicar DW, Gery I.

Immunology. 2013 Dec;140(4):475-82. doi: 10.1111/imm.12158.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk